|
ITGB3BP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.44570000000378E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.628200E-04 |
| Normal-vs-Stage2 |
5.184300E-02 |
| Normal-vs-Stage3 |
1.042020E-01 |
| Normal-vs-Stage4 |
5.661800E-02 |
| Stage1-vs-Stage2 |
8.384000E-01 |
| Stage1-vs-Stage3 |
3.444600E-01 |
| Stage1-vs-Stage4 |
3.225800E-01 |
| Stage2-vs-Stage3 |
4.577600E-01 |
| Stage2-vs-Stage4 |
3.713800E-01 |
| Stage3-vs-Stage4 |
2.003000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.89447999999759E-05 |
| Normal-vs-AfricanAmerican |
3.029500E-02 |
| Normal-vs-Asian |
8.048200E-01 |
| Caucasian-vs-AfricanAmerican |
6.474100E-02 |
| Caucasian-vs-Asian |
1.897710E-02 |
| AfricanAmerican-vs-Asian |
4.397400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.047030E-04 |
| Normal-vs-Female |
1.556190E-03 |
| Male-vs-Female |
8.619800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.622300E-03 |
| Normal-vs-Extreme_Weight |
3.966300E-04 |
| Normal-vs-Obese |
2.999500E-03 |
| Normal-vs-Extreme_Obese |
3.150000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.496800E-01 |
| Normal_Weight-vs-Obese |
6.475200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.695800E-01 |
| Extreme_Weight-vs-Obese |
7.236000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.696200E-01 |
| Obese-vs-Extreme_Obese |
7.095600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.562300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.25389999999326E-05 |
| Normal-vs-Age(61-80Yrs) |
9.635700E-04 |
| Normal-vs-Age(81-100Yrs) |
3.528400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.111400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.902000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.152400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.650250E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.359800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.215800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.53090000010181E-07 |
| Normal-VS-Type2 PRCC |
3.108600E-01 |
| Normal-VS-KIRP CIMP |
7.353500E-02 |
| Normal-VS-Unclassified PRCC |
1.588020E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.3923999999973E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.277800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.481100E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.983400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.835400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.222400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.531800E-02 |
| Normal-vs-N1 |
2.475600E-02 |
| Normal-vs-N2 |
3.374400E-01 |
| N0-vs-N1 |
2.178400E-01 |
| N0-vs-N2 |
2.975600E-01 |
| N1-vs-N2 |
8.493200E-01 |
|
|
